108 results
Page 4 of 6
8-K
EX-99.1
2vav oyqkpdj3dj1
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
m2m ajik5xypojq
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
8e3vbroy2mk1k
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.2
hm9hpp8v vt
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
2b06e8 5w
20 May 19
Other Events
8:52am
8-K
EX-99.1
vjt a7ovw
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
31ng30sk
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
pp6 2eyu8f8vbd1ku0
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.2
ntzw5ioz
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
c6s2a
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
in5mtkg7
7 Jan 19
Other Events
7:01am
8-K
EX-99.1
lux6a4f3n4
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
zvn8 o8zekish
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.2
fyg02glz nluxh04h87n
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
j2f47r4pka4f4aiebfe
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am